Development and characterization of solid-lipid microparticles of highly insoluble drug sirolimus

Journal of Bioequivalence and Bioavailability

Volumn 3, Issue 1, 2011, Pages 011-015

  Nanjwade, Basavaraj K ^a   Patel, Didhija J ^a   Parikh, Kemy A ^a   Nanjwade, Veerendra K ^a   Manvi, F V ^a  

^a K L E S S COLLEGE OF PHARMACY   (India)

Author keywords

Biocompatible lipid microparticles; Glyceryl monostearate; Hot homogenization technique; Immunosuppressant; Sirolimus; Solid lipid microparticulates

Indexed keywords

DRUG CARRIER; GLYCEROL STEARATE; RAPAMYCIN; SOLID LIPID MICROPARTICLE; TAUROCHOLIC ACID; UNCLASSIFIED DRUG;

ARTICLE; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG MANUFACTURE; DRUG RELEASE; DRUG STABILITY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMIDITY; PARTICLE SIZE; STORAGE TEMPERATURE;

EID: 79952348217     PISSN: None     EISSN: 09750851     Source Type: Journal    
DOI: 10.4172/jbb.1000050     Document Type: Article

References (15)

1. Sehgal SN (2003) Sirolimus: Its discovery, biological properties, and mechanism of action. Transplant Proc. 35: 7S-14S.
2. Garber K (2001) Rapamycin's resurrection: A new way to target the cancer cell cycle. J Natl Cancer Inst 93: 1517-1519.
3. D.I. Pritchard (2005) Sourcing a chemical succession for cyclosporine from parasites and human pathogens. Drug Discov Today 10: 688-691.
4. Tsang CK, Qi H, Liu LF, Zheng XF (2007) Targeting mammalian target of rapamycin (mTOR) for health and diseases. Drug Discov Today 12: 112-124.
5. GK McEvoy (2002) AHFS drug information. 3706-3727
6. Sanna V, Kirschvink N, Gustin P, Gavini E, Roland I, Delattre L, Evrard B (2003) Preparation and in vivo toxicity study of solid lipid microparticles as carrier for pulmonary administration. AAPS PharmSciTech 5: 1-7.
7. S. Jaspart, P. Bertholet, L. Delattre, B. Evrard (2005) Study of solid lipid microparticles as sustained release delivery system for pulmonary administration. 15th International Symposium on Microencapsulation, Italy
8. Dalpiaz A, Mezzena M, Scatturin A, Scalia S (2008) Solid lipid microparticles for the stability enhancement of the polar drug N6-cyclopentyladenosine. Int J Pharm 355: 81-86.
9. Zhang L, Liu L, Qian Y, Chen Y (2008) The effects of cryoprotectants on the freeze-drying of ibuprofen-loaded solid lipid microparticles (SLM). Eur J Pharm Biopharm 69: 750-759.
10. Dharmala K, Yoo JW, Lee CH (2008) Development of Chitosan-SLN Microparticles for chemotherapy: In vitro approach through efflux-transporter modulation. J Control Release 131: 190-197.
11. Hou D, Xie C, Huang K, Zhu C (2003) The production and characteristics of solid lipid nanoparticles (SLNs). Biomaterials 24: 1781-1785.
12. Reithmeier H, Herrmann J, Göpferich A (2001) Development and characterization of lipid microparticles as a drug carrier for somatostatin. Int J Pharm 218: 133-143.
13. Reithmeier H, Herrmann J, Göpferich A (2001) Lipid microparticles as parenteral controlled release device for peptides. J Control Release 73: 339-350.
14. Kumar VV, Chandrasekar D, Ramakrishna S, Kishan V, Rao YM, et al. (2006) Development and evaluation of nitrendipine loaded solid lipid nanoparticles: Influence of wax and glyceride lipids on plasma pharmacokinetics. Int J Pharm 30: 112-113.
15. Venkateswarlu V, Manjunath K (2004) Preparation, characterization and invitro release kinetics of clozapine solid lipid nanoparticles. J Control Release 95: 627-638.